These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

162 related articles for article (PubMed ID: 2901681)

  • 1. Depletion of monoamine transmitters by tetrabenazine in brain tissue in Huntington's disease.
    Pearson SJ; Reynolds GP
    Neuropharmacology; 1988 Jul; 27(7):717-9. PubMed ID: 2901681
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Tetrabenazine: for chorea associated with Huntington's disease.
    Scott LJ
    CNS Drugs; 2011 Dec; 25(12):1073-85. PubMed ID: 22133328
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Tetrabenazine (Xenazine) for Huntington's chorea.
    Med Lett Drugs Ther; 2009 Jan; 51(1304):7-8. PubMed ID: 19172140
    [No Abstract]   [Full Text] [Related]  

  • 4. Tetrabenazine, a monoamine-depleting drug used in the treatment of hyperkinetic movement disorders.
    Guay DR
    Am J Geriatr Pharmacother; 2010 Aug; 8(4):331-73. PubMed ID: 20869622
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Neurochemical alterations in Huntington's chorea: a study of post-mortem brain tissue.
    Spokes EG
    Brain; 1980 Mar; 103(1):179-210. PubMed ID: 6102490
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Deutetrabenazine in the treatment of Huntington's disease.
    Richard A; Frank S
    Neurodegener Dis Manag; 2019 Feb; 9(1):31-37. PubMed ID: 30624137
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Deutetrabenazine for the treatment of Huntington's chorea.
    Bashir H; Jankovic J
    Expert Rev Neurother; 2018 Aug; 18(8):625-631. PubMed ID: 29996061
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Review of deutetrabenazine: a novel treatment for chorea associated with Huntington's disease.
    Dean M; Sung VW
    Drug Des Devel Ther; 2018; 12():313-319. PubMed ID: 29497277
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Tetrabenazine in the treatment of Huntington's chorea and other hyperkinetic movement disorders.
    Toglia JU; McGlamery M; Sambandham RR
    J Clin Psychiatry; 1978 Jan; 39(1):81-7. PubMed ID: 147268
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Role of tetrabenazine for Huntington's disease-associated chorea.
    Poon LH; Kang GA; Lee AJ
    Ann Pharmacother; 2010 Jun; 44(6):1080-9. PubMed ID: 20442355
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Monoamine transmitters and their metabolites in the basal ganglia of Huntington's disease and control postmortem brain.
    Walsh FX; Bird ED; Stevens TJ
    Adv Neurol; 1982; 35():165-9. PubMed ID: 6183949
    [No Abstract]   [Full Text] [Related]  

  • 12. Intranasal delivery of tetrabenazine nanoemulsion via olfactory region for better treatment of hyperkinetic movement associated with Huntington's disease: Pharmacokinetic and brain delivery study.
    Arora A; Kumar S; Ali J; Baboota S
    Chem Phys Lipids; 2020 Aug; 230():104917. PubMed ID: 32439327
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Neurochemical-clinical correlates in Huntington's disease--applications of brain banking techniques.
    Reynolds GP; Pearson SJ
    J Neural Transm Suppl; 1993; 39():207-14. PubMed ID: 8103075
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Production of catalepsy and depletion of brain monoamines by a butyrophenone derivative.
    Fuenmayor LD; Vogt M
    Br J Pharmacol; 1979 Sep; 67(1):115-22. PubMed ID: 574039
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Neocortical neurotransmitter markers in Huntington's disease.
    Pearson SJ; Reynolds GP
    J Neural Transm Gen Sect; 1994; 98(3):197-207. PubMed ID: 7748520
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Neurochemical abnormalities in Huntington's disease: neurotoxic mechanisms and neurotransmitter changes.
    Reynolds GP; Pearson SJ
    J Neurol Sci; 1992 Dec; 113(2):230-3. PubMed ID: 1362587
    [No Abstract]   [Full Text] [Related]  

  • 17. Tetrabenazine in the treatment of Huntington's chorea.
    Huang CY; McLeod JG; Holland RT; Elliot C
    Med J Aust; 1976 Apr; 1(16):583-4. PubMed ID: 132600
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Recent neurobiological and related pharmaco-therapeutic acquisitions in Huntington's chorea].
    Carolei A; Del Castillo G
    Clin Ter; 1979 Sep; 90(6):591-621. PubMed ID: 43793
    [No Abstract]   [Full Text] [Related]  

  • 19. Tetrabenazine for Huntington's chorea.
    Soutar CA
    Br Med J; 1970 Oct; 4(5726):55. PubMed ID: 4248502
    [No Abstract]   [Full Text] [Related]  

  • 20. Valbenazine as treatment for Huntington's disease chorea.
    Heim B; Seppi K
    Lancet Neurol; 2023 Jun; 22(6):459-460. PubMed ID: 37210087
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.